Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

High Cannabidiol (CBD) Standardized Extract for Aromatase Inhibitor-Induced Arthralgia - A Randomized Controlled Double Blind Clinical Trial

NCT06538389 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT06538389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06538389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
High Cannabidiol (CBD) Standardized Extract for Aromatase Inhibitor-Induced Arthralgia - A Randomized Controlled Double Blind Clinical Trial
Lead sponsor
City of Hope Medical Center
Phase
Phase 2
Overall status
Suspended
Start date
August 26, 2024
Completion date
January 24, 2027
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage 0 breast cancer ajcc v8, anatomic stage i breast cancer ajcc v8, anatomic stage ii breast cancer ajcc v8, anatomic stage iiia breast cancer ajcc v8, breast adenocarcinoma, breast ductal carcinoma in situ, estrogen receptor-positive breast carcinoma, progesterone receptor-positive breast carcinoma